about
Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulationKRAS, EGFR, PDGFR-α, KIT and COX-2 status in carcinoma showing thymus-like elements (CASTLE)Mutations of epigenetic regulatory genes are common in thymic carcinomasSunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.Emerging treatment options for patients with recurrent advanced thymic epithelial tumorsThymic neoplasm: a rare disease with a complex clinical presentationCirculating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors.Thymic malignancies: from clinical management to targeted therapies.Thymoma patients treated in a phase I clinic at MD Anderson Cancer Center: responses to mTOR inhibitors and molecular analyses.Chemotherapy and targeted agents for thymic malignancies.Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant MelanomaSuccessful Use of Erlotinib in Treating Recurrent Thymic Carcinoma: A Case Report.Validation of a next-generation sequencing assay for clinical molecular oncology.GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.Imatinib mesylate in thymic epithelial malignancies.Thymic carcinomas: clinicopathologic study of 37 cases from a single institution.[Research status of molecular targeted therapy in thymic epithelial tumors].EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes.
P2860
Q33655180-B5F81D20-A101-46AD-9191-1BC1BF8E6140Q33835833-21EA4C01-D522-4116-BDE7-5471A82A5882Q34648225-F19966AD-5F68-46F9-B5FA-BE1C12AA9858Q35462240-71DDB933-A505-412A-891D-0BAD773BFA60Q36228352-7EBF49C1-8B98-49F0-9854-FD562D7C9EF4Q36753888-DFE29263-E204-4DAA-91BF-BEACB0616934Q36843755-3B8E7090-A950-4A37-AF88-288A894C1861Q36910414-1E051E94-E6E3-41A1-BCEB-2809F425D8ACQ37132244-A5171C46-426C-41D5-B5D2-8A0992662A95Q38010806-7AB36BFC-33CF-4546-A9AB-FE76AEA06D78Q38269843-65014F60-B9AF-4109-A34D-D14643489851Q38400475-52E53E3A-FDEE-408F-AE25-36A3A8B78E42Q40007423-69503E13-77EF-45C2-A4A6-06EA5C5218BBQ45327994-6AD32E2C-8149-4476-9FE1-D4F0D3A77110Q45823548-371E9413-60CF-410D-BA5A-31E339862485Q46228676-C349BF50-E3DC-4158-8524-EA9A3EA9FC24Q51024689-A5D415FC-CE63-4261-8BFC-AE9188300A02Q51280693-CF112AB8-92B0-438B-BEF2-D9EE624372B6Q55439056-717B11E4-3F4E-431C-B293-8FA8C6048721Q55516288-E4CE5A42-5090-4B96-9752-7BA7B3F05596
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Thymic tumors: relevant molecular data in the clinic.
@ast
Thymic tumors: relevant molecular data in the clinic.
@en
type
label
Thymic tumors: relevant molecular data in the clinic.
@ast
Thymic tumors: relevant molecular data in the clinic.
@en
prefLabel
Thymic tumors: relevant molecular data in the clinic.
@ast
Thymic tumors: relevant molecular data in the clinic.
@en
P1476
Thymic tumors: relevant molecular data in the clinic.
@en
P2093
Nicolas Girard
P304
P356
10.1097/JTO.0B013E3181F209B9
P433
10 Suppl 4
P577
2010-10-01T00:00:00Z